New hope for advanced cervical cancer patients in clinical trial
NCT ID NCT07177716
Summary
This study is testing whether new drug combinations work better than standard chemotherapy for advanced cervical cancer that has returned or spread. Researchers will compare LB1410 plus lenvatinib, with or without another drug called LB4330, against chemotherapy chosen by doctors. The trial aims to see if these combinations help shrink tumors and extend survival for patients who have already tried other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.